Xiang H Peng
Overview
Explore the profile of Xiang H Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
191
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juarez P, Fournier P, Mohammad K, McKenna R, Davis H, Peng X, et al.
Oncotarget
. 2017 Nov;
8(49):86447-86462.
PMID: 29156807
More efficient therapies that target multiple molecular mechanisms are needed for the treatment of incurable bone metastases. Halofuginone is a plant alkaloid-derivative with antiangiogenic and antiproliferative effects. Here we demonstrate...
2.
Juarez P, Mohammad K, Yin J, Fournier P, McKenna R, Davis H, et al.
Cancer Res
. 2012 Sep;
72(23):6247-56.
PMID: 23002206
TGF-β derived from bone fuels melanoma bone metastases by inducing tumor secretion of prometastatic factors that act on bone cells to change the skeletal microenvironment. Halofuginone is a plant alkaloid...
3.
Mohammad K, Javelaud D, Fournier P, Niewolna M, McKenna C, Peng X, et al.
Cancer Res
. 2010 Nov;
71(1):175-84.
PMID: 21084275
Melanoma often metastasizes to bone where it is exposed to high concentrations of TGF-β. Constitutive Smad signaling occurs in human melanoma. Because TGF-β promotes metastases to bone by several types...